Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Clinical Services: To outsource or To Not Outsource, That Is the Question

When providers think of purchased services, their minds typically go to facility support, IT, and ancillary services. However, this  scope is too limited and doesn’t encompass the full breadth of what falls under the definition of purchased services. The fact is, there are over 250 clinical services that are categorized as a purchased service including pharmacy compounding…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

When providers think of purchased services, their minds typically go to facility support, IT, and ancillary services. However, this scope is too limited and doesn’t encompass the full breadth of what falls under the definition of purchased services. The fact is, there are over 250 clinical services that are categorized as a purchased service including pharmacy compounding services, dialysis services, imaging services, and neurology services.

Another way to describe this is to say that all “clinical services” could potentially be a purchased service, but are not necessarily the the most commonly known purchased services categories such as lawn care, medical waste disposal, or courier services that hospital administrators typically outsource. Because clinical services can be performed by skilled clinicians within the hospital, it can be challenging for healthcare organization leaders to determine whether or not outsourcing these types of services will affect quality of care and ultimately the total costs to serve patients.

Let’s take a closer look at the items found under the “clinical services” umbrella and identify both the questions to ask and typical tasks to perform to determine whether or not they should be outsourced. As with all decisions involving purchased services, but perhaps even more so with services that fall under the clinical category, the goal of choosing to outsource, is to help your healthcare organization save money while continuing to provide the high standard of care your patients expect.

  1. Start by comparing costs: Clinical services, like other purchased services categories, must be either outsourced or performed by facility personnel. Many providers should begin by comparing department profit and loss versus an outsourced firm’s cost model to determine what makes the most sense for each given department. There will likely not be a one-size-fits-all
  1. Perform clinical oversight: Though other purchased services areas may need little oversight, clinical services that are outsourced will need regular and rigorous clinical oversight to ensure they run smoothly and consistently attain the desired results. Department leaders in clinical areas must perform regular analysis of an outsourced firm’s results to determine whether their costs and patient outcomes have changed. Incorporating these data points into regularly scheduled Value Analysis Team (VAT) meetings will ensure consistent quality and outcomes.
  1. Find out if your outsourced firm has best-in-class results:Providers that outsource clinical areas are attempting to obtain the scale and best practices of the outsourced firm. Therefore, it is imperative that clinical leaders and supply chain leaders leverage the data and scale of their outsourced firm to achieve best-in-class results and continuous improvement. Don’t settle for “good enough.”
  1. Schedule regular reviews: Setting an outsourced service on autopilot won’t yield stellar results. Partnering with the outsourced service provider to review optimization opportunities and key performance data will help with continuous improvement and determine that the value of outsourcing isn’t falling away over time.

Every year, hospitals in America waste more than $50 billion on healthcare purchased services—including clinical services. Uncover millions in savings easier and faster with Valify. Valify is the only 100% dedicated web-based solution that allows healthcare organizations to quickly identify, benchmark and track savings in hospital purchased services.

Read more at getvalify.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Dental practice exits are turning into multi-year projects, not last-year decisions

Dental practice exits are turning into multi-year projects, not last-year decisions

Dental practice exits now take 3–5+ years of prep. Dental Economics says associate-to-buyout timelines often run three to five-plus years. That pushes revenue-cycle controls, buy-sell terms, and tax structure earlier, before a buyer appears.

  • 01A practical benchmark is emerging for succession: bringing in an associate with intent to buy can take a minimum of three years and often more than five, according to Dental Economics.
  • 02If accounts receivable looks “high,” it may be a bookkeeping and posting problem before it is a payer problem, a revenue-cycle diagnostic Group Dentistry Now says shows up frequently at scale.
  • 03Exit planning is now an operating system project: valuation, tax positioning, and transition support belong in the same workstream, because deal structure can lock in or foreclose tax options, per Dental Economics.

Sep 4, 2026

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com closed $220 million in equity and debt. It’s expanding its U.S. imaging network plus API-based scheduling and results delivery. For health plans and employers, imaging is starting to look like a platform procurement and integration decision, not a directory problem.

  • 01If imaging access is bought via an API, the real spec becomes integration depth: two-way scheduling plus results routing into the EMR, according to Business Wire.
  • 02Scan.com’s mix of $90M equity and $130M debt earmarked for M&A and working capital points to a fast-changing imaging provider network, which can help access but demands discipline in contracting and integration testing.
  • 03The same week’s funding news for Elucid ($55M) suggests AI imaging vendors will keep pushing toward FDA-cleared workflow insertions, a different buying path than network-layer platforms.

Sep 4, 2026

MD&M West 2026 exhibitors pitch audit-ready, AI-ready device platforms

MD&M West 2026 exhibitors pitch audit-ready, AI-ready device platforms

MD&M West 2026 exhibitor messaging suggests compliance testing and AI-ready compute are becoming early decisions, not afterthoughts. Medical Economics described 2026 as a period shaped by rapid technological change, regulatory scrutiny and ongoing economic uncertainty. Medical Design & Outsourcing’s MD&M West 2026 preview points to exhibitors highlighting test equipment, contract manufacturing and other launch support services.

  • 01If a device roadmap includes AI features, the critical path shifts toward data and software evidence that regulators can audit, which means earlier lock-in of compute platforms and test plans, pulling verification and validation into supplier selection.
  • 02MD&M West exhibitor messaging suggests verification and validation capacity is becoming a procurement problem, with rentals and lab-ready gear positioned as a way to avoid booking delays and re-tests, according to Medical Design & Outsourcing.
  • 03With imaging and other new procedural and device concepts moving fast, manufacturing leaders should expect more frequent line-change decisions and component qualification work, as GE HealthCare's photon-counting CT CE mark reported by MedTech Dive and MDDI's New Technologies coverage illustrate.

Sep 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512